Ignite Creation Date:
2024-05-05 @ 4:37 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00281580
Status:
COMPLETED
Last Update Posted:
2014-03-27
First Post:
2006-01-24
Brief Title:
Telmisartan Micardis and Amlodipine Norvasc - Factorial Design Study for the Treatment of Hypertension
Sponsor:
Boehringer Ingelheim
Organization:
Boehringer Ingelheim
Study Overview
Official Title:
A Randomized Double-blind Double-dummy Placebo-controlled 4x4 Factorial Design Trial to Evaluate Telmisartan 20 40 and 80 mg Tablets in Combination With Amlodipine 25 5 and 10 mg Capsules After Eight Weeks of Treatment in Patients With Stage I or II Hypertension With an ABPM Sub-study
Status:
COMPLETED
Status Verified Date:
2014-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To demonstrate that Micardis and Norvasc when used together are more effective at lowering blood pre ssure
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2008-000874-19 | EUDRACT_NUMBER | EudraCT | None |